Legend Biotech (LEGN) Income from Non-Controlling Interests (2020 - 2025)
Legend Biotech's (LEGN) quarterly Income from Non-Controlling Interests came in at $60.7 million in Q1 2025, up 226.54% YoY from $18.6 million in Q1 2024, and down 1.89% on a QoQ basis from $61.9 million in Q3 2024.
Legend Biotech (LEGN) Income from Non-Controlling Interests (2020 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 6 years of Income from Non-Controlling Interests data on file, last reported at $60.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 63.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 60.73 Mn |
| Sep 30, 2024 | 61.90 Mn |
| Jun 30, 2024 | -10.54 Mn |
| Mar 31, 2024 | -47.99 Mn |
| Sep 30, 2023 | -20.24 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | 13.51 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | -1.04 Mn |
| Mar 31, 2021 | 4.35 Mn |
| Sep 30, 2020 | -586,000.00 |